Mirion Technologies, Inc. (NYSE:MIR - Get Free Report) has received an average rating of "Moderate Buy" from the eleven analysts that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $25.5556.
A number of brokerages have issued reports on MIR. Jefferies Financial Group initiated coverage on shares of Mirion Technologies in a research note on Thursday, September 3rd. They set a "buy" rating and a $20.00 price objective on the stock. B. Riley Financial dropped their target price on shares of Mirion Technologies from $29.00 to $27.00 and set a "buy" rating for the company in a research report on Thursday, July 30th. Morgan Stanley cut their price target on shares of Mirion Technologies from $27.00 to $25.00 and set an "equal weight" rating for the company in a report on Monday, July 13th. Citigroup cut their price target on shares of Mirion Technologies from $28.00 to $24.00 and set a "buy" rating for the company in a report on Thursday, July 30th. Finally, The Goldman Sachs Group reiterated a "buy" rating and set a $23.00 price target on shares of Mirion Technologies in a research report on Wednesday, July 29th.
Get Our Latest Stock Report on Mirion Technologies
Mirion Technologies Stock Performance
NYSE:MIR opened at $15.98 on Friday. The stock has a fifty day moving average price of $15.83 and a 200-day moving average price of $17.85. The company has a market cap of $3.98 billion, a price-to-earnings ratio of 159.85 and a beta of 1.05. The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.63 and a current ratio of 3.20. Mirion Technologies has a fifty-two week low of $14.11 and a fifty-two week high of $30.28.
Mirion Technologies (NYSE:MIR - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.02. The company had revenue of $266.80 million for the quarter, compared to analyst estimates of $269.32 million. Mirion Technologies had a return on equity of 6.59% and a net margin of 2.39%.Mirion Technologies's quarterly revenue was up 19.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.11 EPS. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. As a group, equities analysts anticipate that Mirion Technologies will post 0.54 EPS for the current fiscal year.
Institutional Investors Weigh In On Mirion Technologies
A number of large investors have recently modified their holdings of MIR. Stephens Investment Management Group LLC acquired a new position in Mirion Technologies in the 4th quarter valued at approximately $18,969,000. Tredje AP fonden acquired a new position in shares of Mirion Technologies during the fourth quarter worth $6,576,000. Rockefeller Capital Management L.P. lifted its holdings in shares of Mirion Technologies by 17.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,139,037 shares of the company's stock worth $26,676,000 after purchasing an additional 167,454 shares during the period. Lisanti Capital Growth LLC grew its stake in shares of Mirion Technologies by 133.3% in the fourth quarter. Lisanti Capital Growth LLC now owns 156,740 shares of the company's stock worth $3,671,000 after purchasing an additional 89,565 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in shares of Mirion Technologies by 3.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 5,248,506 shares of the company's stock worth $122,920,000 after purchasing an additional 193,914 shares during the last quarter. Institutional investors and hedge funds own 78.51% of the company's stock.
Mirion Technologies Company Profile
(
Get Free Report)
Mirion Technologies, Inc develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.
The company's offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Mirion Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mirion Technologies wasn't on the list.
While Mirion Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.